AbbVie Execs Put 'Profits Over Compliance,' Investor Says
AbbVie Inc. executives have been hit with a new suit over allegations the company illegally marketed its drug Humira, this time from an investor who says the company's top brass prioritized...To view the full article, register now.
Already a subscriber? Click here to view full article